Field trial of inactivated oral cholera vaccines in Bangladesh: Results from 5 years of follow-up

Vaccine

Volumn 14, Issue 2, 1996, Pages 162-166

  Van Loon, F P L ^a,b   Clemens, J D ^a,c   Chakraborty, J ^a   Rao, M R ^a,c   Kay, B A ^a,d   Sack, D A ^a,e   Yunus, Md ^a   Ali, Md ^a   Svennerholm, A M ^f   Holmgren, J ^f  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NONE

Author keywords

Bangladesh; Cholera; Oral vaccination

Indexed keywords

CHOLERA VACCINE;

ADULT; ARTICLE; BANGLADESH; CHILD; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; VACCINATION; VIBRIO CHOLERAE;

EID: 18744426232     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00122-H     Document Type: Article

References (14)

1. Holmgren, J. and Svennerholm, A.-M. Cholera and the immune response. Prog. Allerg. 1983, 33, 106-119
2. Holmgren, J. et al. The oral B subunit/inactivated whole cell vaccine. In: New Generation Vaccines (Eds Woodrow, G. and Levine, M.M.). Marcel Dekker, New York, 1990, pp. 289-303
3. Clemens, J. et al. Field trial of oral cholera vaccines in Bangladesh: results of three-year follow-up. Lancet 1990, 335, 270-273
4. Clemens, J. et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, 2, 124-127
5. Glass, R. et al. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 1982, 116, 959-970
6. Benenson, A. Review of experience with whole-cell and somatic antigen vaccines. Symposium on Cholera, U.S.-Japan Cooperative Medical Science Program. Sapporo 1976, 228-252
7. Osek, J., Jonson, G., Svennerholm, A.-M. and Holmgren, J. Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera. Infect. Immun. 1994, 62, 2901-2907
8. Samadi, A. et al. Classical V. biotype displaces El Tor in Bangladesh. Lancet 1983, i, 805-807
9. Mosley, W.H. et al. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 4. Five years of observation with a practical assessment of the role of a cholera vaccine in cholera control programmes. Bull. WHO 1972, 47, 229-238
10. Mosley, W.H. et al. Field trial of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh - three years of observation. Bull. WHO 1973, 49, 381-387
11. Tape, S. and Cvjetanovic, B. Controlled field trial on the effectiveness of one or two doses of acetone-inactivated and dried typhoid vaccine. Bull. WHO 1975, 52, 75-80
12. Clemens, J. et al. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh. Int. J. Epidemiol. 1993, 22, 724-730
13. Tauxe, R.V. and Blake, P.A. Epidemic cholera in Latin America. J. Am. Med. Assoc. 1992, 267, 1388-1390
14. International Centre for Diarrhoeal Disease Research, Bangladesh, Cholera Working Group. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae 0139 synonym Bengal. Lancet 1993, 342, 387-390